|
1
|
Li LY, Yang JF, Rong F, Luo ZP, Hu S, Fang
H, Wu Y, Yao R, Kong WH, Feng XW, et al: ZEB1 serves an oncogenic
role in the tumourigenesis of HCC by promoting cell proliferation,
migration, and inhibiting apoptosis via Wnt/β-catenin signaling
pathway. Acta Pharmacol Sin. 42:1676–1689. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ichikawa T, Sano K and Morisaka H:
Diagnosis of pathologically early hcc with eob-mri: Experiences and
current consensus. Liver Cancer. 3:97–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gentile D, Donadon M, Lleo A, Aghemo A,
Roncalli M, di Tommaso L and Torzilli G: Surgical treatment of
hepatocholangiocarcinoma: A systematic review. Liver Cancer.
9:15–27. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie KL, Zhang YG, Liu J, Zeng Y and Wu H:
MicroRNAs associated with HBV infection and HBV-related HCC.
Theranostics. 4:1176–1192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hall CL, Kang S, MacDougald OA and Keller
ET: Role of Wnts in prostate cancer bone metastases. J Cell
Biochem. 97:661–672. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu HH, Cao G, Wu XQ, Vaziri ND and Zhao
YY: Wnt signaling pathway in aging-related tissue fibrosis and
therapies. Ageing Res Rev. 60:1010632020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Caspi M, Wittenstein A, Kazelnik M,
Shor-Nareznoy Y and Rosin-Arbesfeld R: Therapeutic targeting of the
oncogenic Wnt signaling pathway for treating colorectal cancer and
other colonic disorders. Adv Drug Deliv Rev. 169:118–136. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhi X, Lin L, Yang S, Bhuvaneshwar K, Wang
H, Gusev Y, Lee MH, Kallakury B, Shivapurkar N, Cahn K, et al:
βII-Spectrin (SPTBN1) suppresses progression of hepatocellular
carcinoma and Wnt signaling by regulation of Wnt inhibitor
kallistatin. Hepatology. 61:598–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li R, Xu J, Wong DS, Li J, Zhao P and Bian
L: Self-assembled N-cadherin mimetic peptide hydrogels promote the
chondrogenesis of mesenchymal stem cells through inhibition of
canonical Wnt/β-catenin signaling. Biomaterials. 145:33–43. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang S, Liu Y, Li MY, Ng CS, Yang SL, Wang
S, Zou C, Dong Y, Du J, Long X, et al: FOXP3 promotes tumor growth
and metastasis by activating Wnt/β-catenin signaling pathway and
EMT in non-small cell lung cancer. Mol Cancer. 16:1242017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei CY, Zhu MX, Yang YW, Zhang PF, Yang X,
Peng R, Gao C, Lu JC, Wang L, Deng XY, et al: Downregulation of
RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and
stemness via CD44 and CTTN ubiquitination in melanoma. J Hematol
Oncol. 12:212019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Li M, Li Q, Wang CJ and Xie SQ:
DKK1 promotes hepatocellular carcinoma cell migration and invasion
through β-catenin/MMP7 signaling pathway. Mol Cancer. 12:1572013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Villar J, Cabrera NE, Casula M, Valladares
F, Flores C, López-Aguilar J, Blanch L, Zhang H, Kacmarek RM and
Slutsky AS: WNT/β-catenin signaling is modulated by mechanical
ventilation in an experimental model of acute lung injury.
Intensive Care Med. 37:1201–1209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Russell JO and Monga SP: Wnt/β-catenin
signaling in liver development, homeostasis, and pathobiology.
Annual Rev Pathol. 13:351–378. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang R, Lin HM, Broering R, Shi XD, Yu
XH, Xu LB, Wu WR and Liu C: Dickkopf-1 contributes to
hepatocellular carcinoma tumorigenesis by activating the
Wnt/β-catenin signaling pathway. Signal Transduct Target Ther.
4:542019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Rajasekaran M, Xia H, Zhang X,
Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BK, Ooi LL,
et al: The microtubule-associated protein PRC1 promotes early
recurrence of hepatocellular carcinoma in association with the
Wnt/β-catenin signalling pathway. Gut. 65:1522–1534. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zuo Q, He J, Zhang S, Wang H, Jin G, Jin
H, Cheng Z, Tao X, Yu C, Li B, et al: PPARγ Coactivator-1α
suppresses metastasis of hepatocellular carcinoma by inhibiting
warburg effect by PPARγ-dependent WNT/β-catenin/Pyruvate
dehydrogenase kinase isozyme 1 axis. Hepatology. 73:644–660. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wardhani LO, Matsushita M, Iwasaki T,
Kuwamoto S, Nonaka D, Nagata K, Kato M, Kitamura Y and Hayashi K:
Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor
microenvironment is associated with merkel cell polyomavirus status
and prognosis in merkel cell carcinoma. Hum Pathol. 84:52–61. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheong JE and Sun L: Targeting the
IDO1/TDO2-KYN-AhR pathway for cancer immunotherapy-challenges and
opportunities. Trends Pharmacol Sci. 39:307–325. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chung DJ, Rossi M, Romano E, Ghith J, Yuan
J, Munn DH and Young JW: Indoleamine 2,3-dioxygenase-expressing
mature human monocyte-derived dendritic cells expand potent
autologous regulatory T cells. Blood. 114:555–563. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fallarino F, Grohmann U, You S, McGrath
BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi
C, et al: The combined effects of tryptophan starvation and
tryptophan catabolites down-regulate T cell receptor zeta-chain and
induce a regulatory phenotype in naive T cells. J Immunol.
176:6752–6761. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li S, Zhang W, Wu C, Gao H, Yu J, Wang X,
Li B, Jun Z, Zhang W, Zhou P, et al: HOXC10 promotes proliferation
and invasion and induces immunosuppressive gene expression in
glioma. FEBS J. 285:2278–2291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li S, Weng J, Song F, Li L, Xiao C, Yang W
and Xu J: Circular RNA circZNF566 promotes hepatocellular carcinoma
progression by sponging miR-4738-3p and regulating TDO2 expression.
Cell Death Dis. 11:4522020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Muller AJ, Manfredi MG, Zakharia Y and
Prendergast GC: Inhibiting IDO pathways to treat cancer: Lessons
from the ECHO-301 trial and beyond. Semin Immunopathol. 41:41–48.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee SH, Mahendran R, Tham SM, Thamboo TP,
Chionh BJ, Lim YX, Tsang WC, Wu QH, Chia JY, Tay MHW, et al:
Tryptophan-kynurenine ratio as a biomarker of bladder cancer. BJU
Int. 127:445–453. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmitt M, Metzger M, Gradl D, Davidson G
and Orian-Rousseau V: CD44 functions in Wnt signaling by regulating
LRP6 localization and activation. Cell Death Differ. 22:677–689.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lv YF, Dai H, Yan GN, Meng G, Zhang X and
Guo QN: Downregulation of tumor suppressing STF cDNA 3 promotes
epithelial-mesenchymal transition and tumor metastasis of
osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
Cancer Lett. 373:164–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
D'Amato NC, Rogers TJ, Gordon MA, Greene
LI, Cochrane DR, Spoelstra NS, Nemkov TG, D'Alessandro A, Hansen KC
and Richer JK: A TDO2-AhR signaling axis facilitates anoikis
resistance and metastasis in triple-negative breast cancer. Cancer
Res. 75:4651–4664. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Creelan BC, Antonia S, Bepler G, Garrett
TJ, Simon GR and Soliman HH: Indoleamine 2,3-dioxygenase activity
and clinical outcome following induction chemotherapy and
concurrent chemoradiation in Stage III non-small cell lung cancer.
Oncoimmunology. 2:e234282013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang H, Fang F, Chang R and Yang L:
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting
transforming growth factor β receptor 1 and fibroblast growth
factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu D, Zhang J, Lu Y, Bo S, Li L, Wang L,
Zhang Q and Mao J: miR-140-5p inhibits the proliferation and
enhances the efficacy of doxorubicin to breast cancer stem cells by
targeting Wnt1. Cancer gene therapy. 26:74–82. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu J, Cai H, Wu Y, Fang S and Wang D:
Elevation of FGD5-AS1 contributes to cell progression by improving
cisplatin resistance against non-small cell lung cancer cells
through regulating miR-140-5p/WEE1 axis. Gene. 755:1448862020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lan H, Chen W, He G and Yang S: miR-140-5p
inhibits ovarian cancer growth partially by repression of PDGFRA.
Biomed Pharmacother. 75:117–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guastella AR, Michelhaugh SK, Klinger NV,
Fadel HA, Kiousis S, Ali-Fehmi R, Kupsky WJ, Juhász C and Mittal S:
Investigation of the aryl hydrocarbon receptor and the intrinsic
tumoral component of the kynurenine pathway of tryptophan
metabolism in primary brain tumors. J Neuro Oncol. 139:239–249.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mohapatra SR, Sadik A, Tykocinski LO,
Dietze J, Poschet G, Heiland I and Opitz CA: Hypoxia inducible
factor 1α inhibits the expression of immunosuppressive
tryptophan-2,3-dioxygenase in glioblastoma. Front Immunol.
10:27622019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Greene LI, Bruno TC, Christenson JL,
D'Alessandro A, Culp-Hill R, Torkko K, Borges VF, Slansky JE and
Richer JK: A role for tryptophan-2,3-dioxygenase in CD8 T-cell
suppression and evidence of tryptophan catabolism in breast cancer
patient plasma. Mol Cancer Res. 17:131–139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Azuma A, Kudoh S, Nakashima M and Nagatake
T: A double-blind study of zaltoprofen for the treatment of upper
respiratory tract infection. Pharmacology. 85:41–47. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ohyama T, Sato K, Kishimoto K, Yamazaki Y,
Horiguchi N, Ichikawa T, Kakizaki S, Takagi H, Izumi T and Mori M:
Azelnidipine is a calcium blocker that attenuates liver fibrosis
and may increase antioxidant defence. Br J Pharmacol.
165:1173–1187. 2012. View Article : Google Scholar : PubMed/NCBI
|
